GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, obesity, kidney disease, and other conditions. These drugs mimic GLP-1, a hormone that affects insulin release, slows stomach emptying, and affects satiety. Early studies suggest that GLP-1 drugs can benefit liver health as well. Explore the basics and what liver patients should know about GLP-1s with this month's guests:
- Joe Naglowski, President & CEO, Obesity Action Coalition
- Dr. Janese Laster, Gastroenterologist & founder of Gut Theory Total Digestive Care
Information
- Show
- PublishedMarch 12, 2025 at 12:00 PM UTC
- Length43 min
- Season1
- RatingClean